Obstructive sleep apnea/hypopnea syndrome

Panminerva Medica

Volumn 55, Issue 2, 2013, Pages 191-195

  De Backer, W ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Continuous positive airway pressure; Sleep apnea, obstructive; Sleep disorders

Indexed keywords

ANIMAL; ARTICLE; BREATHING; FEMALE; HUMAN; LUNG; MALE; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; SLEEP DISORDER; SLEEP DISORDERED BREATHING;

ANIMALS; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; LUNG; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESPIRATION; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SLEEP DISORDERS;

EID: 84880102376     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bradley TD, Floras JS. Obstructive sleep apnea and its cardiovascular consequences. Lancet 2009;373:82-93.
2. Chan AS, Lee RW, Cistulli PA. Non-positive airway pressure modalities: mandibular advancement devices/positional therapy. Proc Am Thorac Soc 2008;5:179-84.
3. De Backer WJ, Vos WG, Verhulst SL, De Backer W. Novel imaging techniques using computer methods for the evaluation of the upper airway in patients with sleep-disordered breathing: a comprehensive review. Sleep Med Rev 2008;12:437-47.
4. Jennum P, Riha RL. Epidemiology of sleep apnea/hypopnoea syndrome and sleep-disordered breathing. Eur Respir J 2009;33:907-14.
5. Livy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009;34:243-60.
6. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
7. Marklund M. et al. Non-CPAP therapies in obstructive sleep apnea: mandibular advancement device therapy. Eur Respir J 2012;39:1241-7.
8. McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2001, 164:1459-63.
9. Randerath WJ, Verbraecken J, Andreas S, Bettega G, Boudewyns A, Hamans E et al. Non-CPAP therapies in OSA. Eur Respir J 2011;37:1000-28.
10. [No authors listed]. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
11. Tasali E, Ip MS. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 2008;5:207-17.
12. Verbraecken JA, De Backer WA. Upper airway mechanics. Respiration 2009;78:121-33.
13. Verhulst SL, Schrauwen N, Haentjens D, Rooman RP, Van Gaal L, De Backer WA et al. Sleep-disordered breathing and the metabolic syndrome in overweight and obese children and adolescents. J Pediatr 2007;150:608-12.
14. Won CH, Li KK, Guilleminault C. Surgical treatment of obstructive sleep apnea: upper airway and maxillomandibular surgery. Proc Am Thorac Soc 2008;5:193-9.
15. Young TM, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
16. Younes M, Ostrowski M, Atkar R, Laprairie J, Siemens A, Hanly P. Mechanisms of breathing instability in patients with obstructive sleep apnea. J Appl Physiol 2007;103:1929-41.
17. Ayas NT, Fitz Gerald JM, Fleetham JA, White DP, Schulzer M, Ryan CF et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med 2006;166:977-84.